Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas
Authors:
- D. CroaghDCD. Croagh
- C. ColdhamCCC. Coldham
- P. TanièrePTP. Tanière
- J. BuckelsJBJ. Buckels
- J. IsaacJIJ. Isaac
- D. MayerDMD. Mayer
- P. MuiesanP. Muiesan
- S. BramhallSBS. Bramhall
- D.F. MirzaDMD.F. Mirza
- 1 January 2012
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 38 (1) , 72-79
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Does Portal-Superior Mesenteric Vein Invasion Still Indicate Irresectability for Pancreatic Carcinoma?Annals of Surgical Oncology, 2009
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJAMA, 2007
- Postoperative Morbidity and Long-term Survival After Pancreaticoduodenectomy With Superior Mesenterico−Portal Vein ResectionJournal of Gastrointestinal Surgery, 2006
- Indications and Techniques of Extended Resection for Pancreatic CancerWorld Journal of Surgery, 2006
- Pancreaticoduodenectomy with vascular resection: margin status and survival durationJournal of Gastrointestinal Surgery, 2004
- Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors1Journal of the American College of Surgeons, 2004
- Extended Lymphadenectomy and Vein Resection for Pancreatic Head CancerArchives of Surgery, 2003
- Periampullary AdenocarcinomaAnnals of Surgery, 1998
- Clinical significance of portal invasion by pancreatic head carcinomaSurgery, 1995